Related Experiment Video
Updated: May 14, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Calmodulin as a potential target by which berberine induces cell cycle arrest in human hepatoma Bel7402 cells
1School of Life Sciences and Technology, Tongji University, 1239 Siping Road, Shanghai 200092, China.
Abstract:
Berberine is an isoquinoline alkaloid that has drawn extensive attention because it possesses various biological activities. Several mechanisms have been proposed to interpret the anticancer activity of berberine. However, these explanations are mostly based on its downstream-regulated genes or proteins; information on the direct target proteins that mediate the antiproliferative action of berberine remains unclear. In this study, a computational pipeline based on a ligand-protein inverse docking program and mining of the 'Connectivity MAP' data was adopted to explore the potential target proteins for berberine. The results showed that four proteins, that is calmodulin, cytochrome P450 3A4, sex hormone-binding globulin, and carbonic anhydrase II, were suggested to be the potential targets of berberine. The anticalmodulin property of berberine was demonstrated with an in vitro phosphodiesterase activity assay. Flow cytometric analysis found that G1 cell cycle arrest induced by berberine in Bel7402 cells was enhanced by cotreatment with calmodulin inhibitors. Western blotting results indicated that berberine treatment decreased phosphorylation of calmodulin kinase II and blocked subsequent MEK1 activation as well as p27 protein degradation. These results suggested that calmodulin might play crucial roles in berberine-induced cell cycle arrest in cancer cells.
Insights
Berberine, a natural compound, may fight cancer by targeting calmodulin. This study identifies calmodulin as a key protein involved in berberine
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Berberine exhibits diverse biological activities, including anticancer effects.
- Existing research on berberine's anticancer mechanisms focuses on downstream targets, leaving direct protein interactions unclear.
Purpose of the Study:
- To identify direct protein targets of berberine mediating its antiproliferative effects.
- To investigate the role of calmodulin in berberine's anticancer activity.
Main Methods:
- Computational pipeline using inverse docking and 'Connectivity MAP' data mining.
- In vitro phosphodiesterase activity assay to assess anticalmodulin property.
- Flow cytometry and Western blotting to analyze cell cycle effects and molecular pathways.
Main Results:
- Identified calmodulin, cytochrome P450 3A4, sex hormone-binding globulin, and carbonic anhydrase II as potential berberine targets.
- Demonstrated berberine's anticalmodulin activity in vitro.
- Showed that calmodulin inhibition enhances berberine-induced G1 cell cycle arrest.
- Observed decreased calmodulin kinase II phosphorylation and blocked MEK1 activation/p27 degradation upon berberine treatment.
Conclusions:
- Calmodulin is a potential direct target of berberine.
- Calmodulin plays a significant role in berberine-induced cancer cell cycle arrest.
- This study provides novel insights into the molecular mechanisms of berberine's anticancer action.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Drugs that Stabilize Microtubules
Positive Regulator Molecules